PUBLISHER: The Business Research Company | PRODUCT CODE: 1942527
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942527
Cardiovascular and soft tissue repair patches are artificial tissues created in the laboratory, composed of tissues grown in vitro and polymers. These patches serve the purpose of restoring damaged body tissues, providing mechanical regeneration support for injured myocardium layers, and reinstating the functional characteristics of damaged tissues for the treatment of cardiovascular diseases.
The primary raw materials used in the production of cardiovascular and soft tissue repair patches include ePTFE (expanded Polytetrafluoroethylene), biomaterial and tissue-engineered material, and other relevant raw materials. ePTFE, a material commonly used in medical devices like catheters and cardiac sutures, is composed of tetrafluoroethylene polymer units and is known for its biocompatible properties. The resulting products include synthetic patches and biological patches, with applications ranging from cardiac repair to various heart-related conditions such as atrial septal defect, ventricular septal defect, and vascular repair. The end users of cardiovascular and soft tissue repair patches encompass hospitals, ambulatory surgical centers, and specialty clinics.
Tariffs are impacting the cardiovascular and soft tissue repair patches market by increasing costs of imported biomaterials, polymers, processing equipment, and sterilization technologies. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported patch materials, while Asia-Pacific faces manufacturing cost pressures. These tariffs are increasing treatment costs and slowing adoption in some settings. However, they are also encouraging domestic biomaterial production, regional manufacturing expansion, and innovation in cost-effective tissue repair solutions.
The cardiovascular and soft tissue repair patches market research report is one of a series of new reports from The Business Research Company that provides cardiovascular and soft tissue repair patches market statistics, including cardiovascular and soft tissue repair patches industry global market size, regional shares, competitors with a cardiovascular and soft tissue repair patches market share, detailed cardiovascular and soft tissue repair patches market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular and soft tissue repair patches industry. This cardiovascular and soft tissue repair patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiovascular and soft tissue repair patches market size has grown rapidly in recent years. It will grow from $4.85 billion in 2025 to $5.41 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing incidence of congenital heart defects, expansion of cardiovascular surgical procedures, adoption of synthetic repair patches, advancements in biomaterial science, growing availability of specialized cardiac surgery centers.
The cardiovascular and soft tissue repair patches market size is expected to see rapid growth in the next few years. It will grow to $8.09 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for regenerative cardiovascular treatments, rising investments in tissue engineering research, expansion of advanced cardiac reconstruction procedures, growing focus on absorbable patch materials, increasing adoption of personalized repair solutions. Major trends in the forecast period include increasing adoption of biologic repair patches, rising use of tissue-engineered materials, growing focus on regenerative cardiac therapies, expansion of minimally invasive patch implantation, enhanced emphasis on biocompatibility and healing.
The increasing demand for patches related to cardiac disease is projected to drive the growth of the cardiovascular and soft tissue repair patches market. Cardiac disease encompasses a range of disorders associated with the heart and blood vessels. The rising need for patches addressing cardiac conditions is largely influenced by lifestyle factors, including smoking and alcohol consumption. For instance, in May 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in Georgia, reported that in 2022, heart disease led to 702,880 deaths, accounting for 1 in every 5 fatalities. This equates to one individual succumbing to cardiovascular disease every 33 seconds. Each year, about 805,000 people in the United States suffer a heart attack, of which 605,000 are experiencing their first heart attack, while 200,000 have had a previous heart attack. Thus, the increasing demand for patches related to cardiac disease is expected to drive the cardiovascular and soft tissue repair patches market in the coming years.
Major players in the cardiovascular and soft tissue repair patches market are developing advanced expandable, bio-integrative surgical patches to meet demand for long-term, biocompatible implants that accommodate patient growth and reduce re-interventions. These patches combine bio-absorbable and non-absorbable yarns within a knitted structure coated with cross-linked gelatin; the absorbable portion degrades while native tissue grows in, lowering foreign-body response and inflammation. In July 2023, Teijin Limited received regulatory approval in Japan for SYNFOLIUM(R), a patch designed to prevent blood leakage, promote tissue regeneration, and expand with physiological growth, reducing risks of calcification, stiffening, and immune reactions.
In June 2024, Stryker, a US-based manufacturer of medical equipment, acquired Artelon for an undisclosed sum. This acquisition is intended to expand its product portfolio in joint preservation and soft tissue reconstruction. Artelon focuses on developing innovative biomaterials for soft tissue reinforcement and repair, especially in the areas of sports medicine and extremities procedures. Artelon is based in Georgia and specializes in medical equipment manufacturing.
Major companies operating in the cardiovascular and soft tissue repair patches market are B. Braun, Baxter International Inc., CorMatrix Cardiovascular Inc., CryoLife Inc., Edwards Lifesciences Corporation, LeMaitre Vascular Inc., Anteris Technologies Limited, Abbott Laboratories, Terumo Medical Corporation, Integra LifeSciences Corporation, W. L. Gore & Associates Inc., Medtronic Inc., LifeCell Corporation, ACell Inc., Tissue Regenix Group Plc, Aroa Biosurgery Ltd., LifeNet Health Inc., Cook Medical, Getinge AB, Glycar SA Pty Ltd., Biointegral Surgical Inc., Admedus Ltd., Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew plc, Organogenesis Inc.
North America was the largest region in the cardiovascular and soft tissue repair patches market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular and soft tissue repair patches market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiovascular and soft tissue repair patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cardiovascular and soft tissue repair patches market consists of sales of xenogeneic patch and allogeneic patch. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiovascular And Soft Tissue Repair Patches Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiovascular and soft tissue repair patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiovascular and soft tissue repair patches ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular and soft tissue repair patches market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.